The Drug Science Podcast

Join us in this episode of the Drug Science Podcast, where Prof Jo Neil speaks with Dr Maria Balaet, a computational neuroscientist based at King’s College London. She speaks on her research into cognition, highlighting her Great British Intelligence Test project and its longitudinal findings with regards to drug use. Maria explains the relationship between mental health and drug use during the pandemic, laying out her own in...

Join Prof David Nutt and Prof Rod Flower for a captivating journey into the history of pharmacology.

Rod is emeritus professor of biochemical pharmacology at Queen Mary University of London and co-author of Rang and Dale's Pharmacology, the textbook that has shaped the understanding of generations of medical and science students. His work was pivotal in advancing the knowledge of anti-inflammatory treatments, and his new book, Drugs...

Trigger Warning: This episode contains discussions of childhood sexual abuse, trauma, suicidal thoughts, and mental health challenges. Listener discretion is advised. 

In this episode, Prof Jo Neill speaks with Wendi Rees, the critically acclaimed author of A Christian's Guide to Psychedelics. Wendi reflects on growing up as a preacher's kid under a strict set of household rules, and shares how surviving abuse from her father s...

In this episode, we speak with Dr Dixon Chibanda, a psychiatrist and professor at the London School of Hygiene and Tropical Medicine. He shares how losing a patient to suicide drove him towards community-based mental health care in Zimbabwe. Chibanda discusses the Friendship Bench, a model he built around grandmothers as custodians of local culture, and how listening and storytelling became its foundation. He explores how the appro...

In this episode of the Drug Science Podcast, Dr Hannah Thurgur speaks with Dr Justin Garson, professor of philosophy at CUNY and the author of The Madness Pill, a history of Professor Solomon Snyder and the biological understanding of schizophrenia. He outlines the significant shift to biological paradigms of mental health treatment in the 80s and its ramifications for psychiatry decades later. He dives into the role of different d...

Join us in this episode as Prof Nutt speaks with Dr Andy Barker, a senior psychiatrist, medical cannabis prescriber, and the co-founder of This Native Mind. Andy shares his journey into medical cannabis, detailing the regulatory process for prescribers entering the field. He goes on to discuss the outcomes he’s seen in his own patients, contrasted against backlash from GPs, non-patients, and the broader scientific community. ...

In this episode, we speak with Sarah Tilley, a couple’s therapy pioneer and the CEO and founder of Beautiful Space, a provider of psilocybin programmes for couples. She details how her own divorce led her to this work, emphasizing that issues between couples become emotionally taxing on their children, manifesting in poor mental health and wellbeing. Sarah discusses how she has seen psilocybin, in conjuction with mindfulness ...

In this episode of the Drug Science Podcast, Prof Nutt speaks with David Hillier, a journalist and the creator of the Substack WHAT ARE YOU ON. David  Hillier has been writing about drug culture and mental health for 12 years and shares his journey into the drugs and harm reduction space, describing how a feature he wrote on The Loop cemented the topic as a broader journalistic focus. The conversation largely revolves around c...

In this episode, we speak to Prof Matthew Cobb, professor of zoology at the University of Manchester and author of Crick: A Mind in Motion, which profiles Francis Crick. Matthew shares insights into his own academic background in neurobiology and evolution, explaining the motivation behind his latest book. He delves into the collaborative approaches that fueled Crick's work and explains the complex dynamics between Crick, James Wat...

Join us in this episode of the Drug Science Podcast as Prof Jo Neill speaks with David Orren, CEO of GABA Labs, which has pioneered functional drinks with SENTIA Spirits. David recounts his initial communication with David Nutt and emphasises their shared mission to speak to younger generations’ desires for less harmful alternatives to alcohol. He touches on the neurological underpinnings of the drink and explores the future ...

In this episode, we speak to Dr Lauren Macdonald, a psychiatrist, psychedelic therapist, and group retreat facilitator. She details her path to psychedelics, in particular her cancer diagnosis that left her with existential dread that she felt fully dissipate only after a psychedelic experience. She goes on to discuss her interest in group retreats and treating existential distress. Before closing, she explains problems with the cu...

Join us in this episode as Prof Nutt speaks to Prof Mark Solms, a leading expert on Freud and author of the new book The Only Cure. Mark details his early fascination with neuropsychology that led him to study the neurological underpinnings of sleep and dreams. He explains how some of his own research lent more credence to Freud’s claims and deepened his interest in psychoanalysis. Mark concludes by discussing what the only c...

Join us in this episode as we speak to Dr Harriet de Witt, professor of psychiatry and neuropharmacology at the University of Chicago. She shares how she fell in love with the field, studying the animal model of self-administration, and how that work fed into her later research with human participants. As a leading expert on the pharmacology of MDMA, she explores the subtle differences between amphetamine and MDMA, before talking a...

Join us in this episode as we speak to Dr. Rachel Andrews, an addiction and harm reduction researcher at the University of Bath, and Hannah Dawes, a PSHE teacher and the creator of the podcast The Exchange. The conversation focuses on the prevalence of vaping in schools, particularly exploring the ways in which vapes have been marketed to children and the patterns of use in schools. Rachel provides data from her team’s analys...

In this episode of the Drug Science Podcast, Prof Nutt speaks with Erica Rex, author of the book Seeing What is There, which explores the complex history of psychedelic therapy. She shares her own experiences with psychedelic-assisted therapy, while providing context on the guardrails that are necessary for these treatments to maximize benefits and minimize harms. Viewing psychedelics as therapeutic accelerants, Erica speaks on the...

In this episode, we’re joined by Justin Smith-Ruiu, a philosopher at Université Paris Cité and the author of On Drugs. He discusses his motivations behind the book, rooted in his early experiences with psychedelics and the many cultural roles he has seen them play across different contexts. As the conversation unfolds, Smith-Ruiu reflects on his decision to quit drinking in favor of psychedelics and the profound positive chan...

Join us in this episode as we talk to Robert Schoevers, a professor of psychiatry at the University of Groningen and one of the pioneers of psychedelic-assisted therapy. He explains why human complexity led him to psychiatry, begoring discussing how his early psychedelic research into esketamine aimed to meet the unmet needs of treatment-resistant patients. Schoevers goes on to explore the ways in which his approach to ketamine-ass...

Join us in this episode as we speak with Emma Robinson, a professor of psychopharmacology at the University of Bristol with extensive experience in animal research. She unpacks the regulations surrounding animal research, offering a scientist’s view on animal rights activism, ethical tension, and why this work remains essential. Robinson also delves into the emerging intersection of psychedelics and animal research, describin...

In this episode of the Drug Science Podcast, we talk to Simon Doherty, a journalist and content creator with a focus on harm reduction. He explores how reporting on electronic music and rave culture naturally led to his work on harm reduction. He goes on to dissect Talk to Frank and its flaws in providing accurate, evidence-based information. Finally, by comparing the unique landscape of free parties to the regulated club scene, Do...